Clinical Trial Update: Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This update describes the completed Phase 1/2 safety study of a stem cell transplantation approach for Limbus Corneae Insufficiency Syndrome conducted by IOBA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbus Corneae Insufficiency Syndrome

Drugs mentioned

• Stem cell transplantation

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Limbus Corneae Insufficiency Syndrome | Phase 1, Phase 2 | Status: COMPLETED